期刊文献+

胃上部癌手术保留脾胰清除No.10、11淋巴结的可行性探讨 被引量:4

Study of splenopancreatic-preserving dissection of No.10 and No.11 lymphatic nodes in radical resection for proximal gastric carcinoma
原文传递
导出
摘要 目的探讨胃上部癌手术保留脾脏、胰腺,清除No.10、11淋巴结的可行性。方法回顾性分析采用保留脾脏、胰腺治疗62例胃上部癌患者的手术情况。结果本组62例患者中50例有淋巴结转移(80.6%),No.10转移率为19.4%(12/62),No.11转移率为22.6%(14/62);每组清扫淋巴结数为3~8枚。术后并发症发生率为16.1%。无死亡病例。结论保留脾脏、胰腺,清除No.10、11淋巴结手术操作可行,是胃上部癌一种安全可行的手术方法。 Objective To investigate the feasibility of splenopancreatic-preserving dissection of No. 10 and No. 11 lymph nodes in radical resection for proximal gastric carcinoma. Methods The data of 62 patients with proximal gastric carcinoma undergoing splenopancreatic-preserving dissection of No. 10 and No. 11 lymph nodes were analyzed retrospectively. Results This splenopancreatic-preserving dissection was effective significantly. The incidences of lymphatic metastasis in No. 10 and No. 11 were 19. 4% and 22. 6% respectively, and the incidence of complications was 16. 1%, significantly lower than that(40% ) of non-splenopancreatic-preserving dissection. Conclusions The splenopancreatic-preserving dissection of No. 10 and No. 11 lymph nodes is a safe and feasible method in radical gastrectomy for proximal gastric carcinoma. The surgical procedure is not difficult. With careful operation, the complete clearance of the lymph nodes can be obtained.
出处 《中华胃肠外科杂志》 CAS 2006年第2期131-132,共2页 Chinese Journal of Gastrointestinal Surgery
关键词 胃肿瘤 胰腺 淋巴结清扫术 外科手术 Stomach neoplasms Spleen Pancreas Lymph node excision Surigcal procedures, operative
  • 相关文献

参考文献6

二级参考文献35

  • 1陈峻青.胃癌手术胰尾侧清除的新方法[J].实用外科杂志,1987,7(2):99-99.
  • 2野清隆 重罔宏典 田中显.他.自家脾移植[J].手术,1998,52(7):1005-1005.
  • 3Lee KY, Noh SH, Hyung WJ. Impact of splenectomy for lymph node dissection on long - term surgical outcome in gastric cancer.Ann Surg Oneol, 2001 ;8(5):402-406.
  • 4Roukos DH, Lorenz M, Encke A, et al. Evidence of survival benefit of extended (D2)lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long - term follow-up study. Surgery, 1998; 123:573--578.
  • 5Maehara Y, Moriguchi S, Yoshida M. Splenectomy does not correlate with length of survival in patients undergoing curative total gastrectomy for gastric carcinoma. Univariate and multivariate analyses. Cancer, 1991 ; 15; 67(12): 3006--3009.
  • 6Fass J, Schumpelick. Principles of radical surgery in gastric carcinoma. Hapatogastroentorology, 1989; 36 : 13 -- 21.
  • 7Takahashi M, Fujimoto S, Kobayashi K, et al. Indication for splenectomy combined with total gastrectomy for gastric cancer:analysis of data on 249 gastric cancer patients. Hepatogastroenterology, 1995 ; 42(3): 230--233.
  • 8Ohta K, Nishi M, Nakajima T, et al. Indications for total gastrectomy combined with pancreatieosplenectomy in the treatment of middle gastric cancer. Nippon- Geka- Gakkai- Zasshi, 1989; 90(9) :1326 -- 1333.
  • 9Chikara K, Hiroshi S, Masato N , et al. Indications for pancreaticosplenectomy in advanced gastric cancer. Hepatogastroenterology,2001 ;48(39) :908--912.
  • 10Otsuji E, Yamaguchi T, Sawai K ,et, al. Total gastrectomy with simultaneous pancreaticosplencctomy or splencctomy in patients with advanced gastric carcinoma. Br J Cancer, 1999; 79 ( 11 - 12) : 1789-1793.

共引文献63

同被引文献18

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部